Literature DB >> 2515626

Antibodies to haemorrhagic fever viruses in Madagascar populations.

C C Mathiot1, D Fontenille, A J Georges, P Coulanges.   

Abstract

Sera of 381 adult people from 5 areas in Madagascar were tested by the indirect immunofluorescence method for antibodies against Congo-Crimean haemorrhagic fever and Rift Valley fever viruses (Bunyaviridae), Ebola (strains Zaire and Sudan) and Marburg viruses (Filoviridae), and Lassa virus (Arenaviridae). The highest prevalence rate was that of Ebola virus (4.5%). As no haemorrhagic syndrome has been found associated with this virus, the possible presence of a less pathogenic, antigenically related, strain is discussed. The prevalences of Congo-Crimean haemorrhagic fever and Rift Valley viruses were very low, despite previous viral isolations from potential vectors. No serum reacted against Lassa or Marburg antigens. The results are analysed in the light of the geographical and bioecological characteristics of Madagascar, which is a true 'microcontinent' very different from the African mainland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515626     DOI: 10.1016/0035-9203(89)90519-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Ebola Mysteries and Conundrums.

Authors:  Robert F Garry
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

2.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

3.  Integrated biological-behavioural surveillance in pandemic-threat warning systems.

Authors:  Maureen Miller; Emily Hagan
Journal:  Bull World Health Organ       Date:  2016-11-03       Impact factor: 9.408

Review 4.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

Review 5.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection.

Authors:  Hilary Bower; Judith R Glynn
Journal:  Sci Data       Date:  2017-01-31       Impact factor: 6.444

6.  A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.

Authors:  Luke Nyakarahuka; Ilana J Schafer; Stephen Balinandi; Sophia Mulei; Alex Tumusiime; Jackson Kyondo; Barbara Knust; Julius Lutwama; Pierre Rollin; Stuart Nichol; Trevor Shoemaker
Journal:  BMC Infect Dis       Date:  2020-07-01       Impact factor: 3.090

7.  Disentangling serology to elucidate henipa- and filovirus transmission in Madagascar fruit bats.

Authors:  Cara E Brook; Hafaliana C Ranaivoson; Christopher C Broder; Andrew A Cunningham; Jean-Michel Héraud; Alison J Peel; Louise Gibson; James L N Wood; C Jessica Metcalf; Andrew P Dobson
Journal:  J Anim Ecol       Date:  2019-04-15       Impact factor: 5.606

8.  The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey.

Authors:  I Koksal; G Yilmaz; F Aksoy; S Erensoy; H Aydin
Journal:  Epidemiol Infect       Date:  2013-05-21       Impact factor: 4.434

9.  Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey.

Authors:  Turabi Gunes; Aynur Engin; Omer Poyraz; Nazif Elaldi; Safak Kaya; Ilyas Dokmetas; Mehmet Bakir; Ziynet Cinar
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

Review 10.  Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development.

Authors:  Thomas Tipih; Felicity Jane Burt
Journal:  Biores Open Access       Date:  2020-05-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.